V. Strukov, M. Sergeeva-Kondrachenko, A. Denisova, I. Moiseeva, O. Vinogradova, E. Panina, E. Petrova, N. Galkina, A. Pronkina, O. Gorina, D. Elistratov, S. Burmistrova, D. Agafonov
{"title":"Vascular and renal calcification as a consequence of high-dose calcium and vitamin D drugs","authors":"V. Strukov, M. Sergeeva-Kondrachenko, A. Denisova, I. Moiseeva, O. Vinogradova, E. Panina, E. Petrova, N. Galkina, A. Pronkina, O. Gorina, D. Elistratov, S. Burmistrova, D. Agafonov","doi":"10.29296/25877305-2024-02-15","DOIUrl":null,"url":null,"abstract":"Calcium-containing drugs occupy an important place in the list of anti-osteoporotic agents. Their consumption, often in combination with high doses of vitamin D, has increased significantly over the last couple of decades. Cases of uncontrolled intake of the macronutrient have become more frequent. Aggressive advertising of high-dose calcium supplements with calciferol of foreign production on television played its role in this. Nowadays doctors of various specialties have to face more and more often the consequences of using such preparations. The article describes the mechanism of calcium deposits formation in vessels and kidneys against the background of calcium supplementation. The results of large-scale studies proving the close relationship between high intake of calcium and vitamin D with calcification of vessels, development of cardiovascular diseases and nephrolithiasis are presented. Doubts are raised about the validity and necessity of high-dose calcium supplements in the treatment of skeletal diseases. The possibilities of successful therapy of postmenopausal osteoporosis without the use of such agents are presented on the example of the preparation Osteo-Vit D3, which does not contain calcium and high doses of calciferol, but increases the mineral density of bone tissue and reduces the volume of calcificates in blood vessels and kidneys.","PeriodicalId":23748,"journal":{"name":"Vrach","volume":"241 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vrach","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29296/25877305-2024-02-15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Calcium-containing drugs occupy an important place in the list of anti-osteoporotic agents. Their consumption, often in combination with high doses of vitamin D, has increased significantly over the last couple of decades. Cases of uncontrolled intake of the macronutrient have become more frequent. Aggressive advertising of high-dose calcium supplements with calciferol of foreign production on television played its role in this. Nowadays doctors of various specialties have to face more and more often the consequences of using such preparations. The article describes the mechanism of calcium deposits formation in vessels and kidneys against the background of calcium supplementation. The results of large-scale studies proving the close relationship between high intake of calcium and vitamin D with calcification of vessels, development of cardiovascular diseases and nephrolithiasis are presented. Doubts are raised about the validity and necessity of high-dose calcium supplements in the treatment of skeletal diseases. The possibilities of successful therapy of postmenopausal osteoporosis without the use of such agents are presented on the example of the preparation Osteo-Vit D3, which does not contain calcium and high doses of calciferol, but increases the mineral density of bone tissue and reduces the volume of calcificates in blood vessels and kidneys.
含钙药物在抗骨质疏松药物中占有重要地位。在过去几十年中,含钙药物的服用量大幅增加,通常与大剂量维生素 D 同时服用。无节制地摄入大量营养素的病例也越来越多。电视上大肆宣传国外生产的含有钙化醇的高剂量钙补充剂也是原因之一。如今,各科医生不得不越来越频繁地面对使用此类制剂的后果。文章介绍了在补钙背景下血管和肾脏中钙沉积形成的机制。大规模研究的结果证明,大量摄入钙和维生素 D 与血管钙化、心血管疾病和肾结石的发生密切相关。对高剂量钙补充剂治疗骨骼疾病的有效性和必要性提出了质疑。以不含钙和高剂量钙化醇的制剂 Osteo-Vit D3 为例,介绍了不使用此类制剂成功治疗绝经后骨质疏松症的可能性,该制剂可增加骨组织的矿物质密度,减少血管和肾脏的钙化体积。